an MSK press release about the study describes
The first patient, named Sascha, was preparing to travel to New York to have radiation therapy when she got the call from her oncologist, Andrea Cercek, who said the patient was "stunned and ecstatic" at the news. The MSK doctors behind the study wanted to investigate whether immunotherapy alone could treat cancer, but they never expected it to work this well — and especially could not have foreseen that none of the 12 people in the initial trial had adverse reactions to the drug, known as dostarlimab.
Dr. Alan Venook, a University of California, San Francisco colorectal cancer specialist who wasn't involved in the study, told thethat the lack of side effects means that "either they did not treat enough patients or, somehow, these cancers are just plain different."
'The biggest mistake any performer can make is to look at the audience.'
Then there is no more need for theNCI NCIDirector. 'Hey, gives us their budget NOW.' Other NIH Institutes
yusufpore Cancer is a first time - now reaction to cancer overtakes history! Well hoping our loved ones get to experience the solution soon.
Yeah and we’ll never see it. Cancer makes too much money. Other countries will get it. For profit medicine nations - nope.
I hope whoever discovered and published this has good life insurance. 😬
Law Law Latest News, Law Law Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NatureMedicine - 🏆 451. / 53 Read more »